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Experimental Methods 
Materials: Amino acids 1 and 4 were obtained from Sigma (St. Louis, MO). Amino 
acids 2 and 3 were prepared by alkylation of diethyl acetamidomalonate with the alkyl 
tosylate or alkyl bromide, followed by hydrolysis, decarboxylation and deacylation.[1] 
Amino acid analogs 2 and 3 were used as the racemates in both in vitro and in vivo 
assays. [32P]-radiolabeled sodium pyrophosphate was purchased from NEN Life Sci-
ence Products, Inc (Waltham, MA). Oligonucleotides were synthesized at the Caltech 
Biopolymer Synthesis Center (Pasadena, CA). General cloning was performed in XL-
1 blue cells (Stratagene). Expression strain SG13009 was obtained from Qiagen. 
Synthetase expression and purification: E. coli LeuRS was purified from SG13009 
cells transformed with the plasmid p32leus[2] (which encodes the synthetase under 
the control of an IPTG-inducible promoter), and with the pREP4 repressor plasmid. 
Protein expression was induced at OD600 = 0.6 by addition of IPTG to a final concen-
tration of 0.5 mM. Cells were harvested after 3 hours by centrifugation and lysed by 
sonication. The enzyme was isolated using Ni-NTA agarose resin under native condi-
tions according to the manufacturer’s instructions (Qiagen). Proteins were stored in 
Buffer A/glycerol (50 mM Tris-HCl, 1 mM DTT, 50% glycerol). Aliquots were flash 
frozen in liquid nitrogen and stored at -80°C. The concentration of each enzyme was 
determined by measuring the absorbance at 280 nm under denaturing conditions. 
ATP-PPi exchange assay: Amino acid activation was monitored by an amino acid 
dependent ATP-pyrophosphate (PPi) exchange assay at room temperature[3] in buf-
fer containing HEPES (50 mM, pH 7.6), MgCl2 (20 mM), DTT (1 mM), ATP (2 mM), 
[32P]-PPi (0.5 TBq mol-1, 2 mM), and LeuRS (75 nM). The amino acid concentrations 
varied depending on the activity of the enzyme toward the substrate. Reactions were 
initiated with the addition of LeuRS. Aliquots (20 µL) were quenched using a standard 
quench solution (500 µL) containing PPi (200 mM), HClO4 (7% w/v), and activated 
charcoal (3% w/v). The charcoal was washed twice using a solution of PPi (10 mM) 
and HClO4 (0.5% w/v), and counted using a scintillation counter. Kinetic parameters 
(kcat and Km) were determined by nonlinear regression analysis of curve-fitting of the 
Michaelis-Menten equation. The results reported in Table 1 are averages from tripli-
cate experiments. 
Construction of expression plasmids: The expression plasmid pA1EL was con-
structed as described by Tang et al.[2] It encodes a synthetic leucine zipper protein 
A1 under control of an inducible T5 bacteriophage promoter and the E. coli leuS 
gene with its endogenous promoter. The mutations at position T252 of leuS were in-
troduced by overlap-extension-PCR mutagenesis using the Quikchange site-directed 
mutagenesis kit (Stratagene) and pA1EL as a template. The primer pairs were used 
to generate the tyrosine, isoleucine and valine mutations. The integrity of the coding 
regions was confirmed through DNA sequencing. The plasmids carrying the T252Y, 
T252I, and T252V mutants were designated as pA1T252Y, pA1T252I, and 
pA1T252V respectively. Overexpression of LeuRS was verified by SDS-PAGE of 
whole cell lysates from overnight cultures. 
Analog Incorporation Assay: The leucine auxotrophic strain LAM1000[4] was trans-
formed with pA1EL, with pA1T252Y (or pA1T252I or pA1T252V), and with pREP4 to 
yield the A1 expression strains LAM1000/(pA1EL, or pA1T252Y, or pA1T252I, or 
pA1T252V)/pREP4. M9 (200 mL) containing 20 canonical amino acids (40 mg L-1), 
MgSO4 (1 mM), CaCl2 (1 mM), glucose (0.4% w/v), thiamine (5 mg mL-1), ampicillin 
(200 mg mL-1), and kanamycin (25 mg mL-1), was inoculated with an overnight cul-
ture (1 mL) of the expression strain. When the turbidity of the culture reached an 
OD600 between 0.9 and 1.0, the cells were sedimented and the cell pellet was 
washed with salt solution (0.9% NaCl in H2O) three times. The cells were resuspend-
ed in fresh M9 medium with 16 natural amino acids (M9 –LIVM medium). Leu, Ile, Val, 
and Met were not added to the medium (Ile, Val, and Met were omitted in order to re-
duce background expression levels as previously described).[2] Test tubes containing 
aliquots (10 mL) of the resulting culture were prepared and supplemented with 2 (100 
mg L-1), 3 (200 mg L-1) or 4 (320 mg L-1). Leucine (40 mg L-1) was added to a separ-
ate culture (10 mL) as a positive control. A culture without additional amino acids (or 
any analog) served as the negative control. Protein expression was induced by addi-
tion of IPTG to the culture at a final concentration of 1 mM. Cultures were grown for 3 
h and the cells were collected by centrifugation (5000g, 10 min, 4°C), resuspended in 
Buffer B (600 µL, 8.0 M urea, 0.1 M NaH2PO4, 0.01 M Tris, pH 8.0) and frozen at 
-80°C. Protein expression was monitored by SDS-PAGE  and visualized by Coomas-
sie Brilliant Blue staining. 
Protein composition analysis: The target protein A1 was purified from cells resus-
pended in Buffer B (600 µL) by using Ni-NTA spin columns (Qiagen) according to the 
manufacturer’s instructions. A1 protein was eluted in Buffer B (400 µL), pH 4.5. A 
portion of the eluent (10 µL) was diluted in ammonium bicarbonate (90 µL, 50 mM 
(NH4)2CO3). Trypsin stock solution (5 µL, 0.1 µg µL-1) was added, and the sample 
was incubated at room temperature overnight. The reaction was quenched by addi-
tion of trifluoroacetic acid (TFA, 2 µL). The reaction mixture was subjected to C18 
ZipTip (Millipore) purification, and peptide fragments were eluted (3 µL) in a solution 
of TFA (0.1%) and CH3CN (50%). A portion (1 µL) of C18 ZipTip eluent was used for 
tryptic MALDI analysis. The remaining volume of spin column eluent (390 µL) was 
dialyzed against water extensively and lyophilized to a fluffy powder. The powder 
was sent directly for MALDI mass spectrometry and amino acid analysis. 
Modification of Ketone Side Chains: Purified proteins containing ketone function-
alities were dissolved in PBS buffer (200 µL, pH 6.0) and added to biotin hydrazide 
(BH, 20 µL, 5 mM) in PBS. Protein/BH mixtures were incubated at room temperature 
for 1 to 1.5 h. Reaction solutions were then washed twice with distilled water using a 
buffer-exchange column (Millipore, MWCO = 5 kDa). Standard western blotting pro-
cedures were used to identify proteins modified with BH. 
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